Hyperbaric Oxygen Therapy

A Pilot Study to Determine the Safety and Efficacy of Incorporating Hyperbaric Oxygen Therapy Into RIC Fludarabine and Melphalan and Allogeneic Hematopoietic Stem/Progenitor Transplantation

More Information

Trial Status
Accepting patients
Trial Phase
Phase 1
Enrollment
24 patients (estimated)
Sponsors
University of Rochester Medical Center Wilmot Cancer Center
Tags
Allogeneic Stem Cell Transplant, Chemotherapy
Trial Type
Treatment
Last Update
10 months ago
SparkCures ID
1650
NCT Identifier
NCT03964506

Real People. Real Support.

Need help connecting with this clinical trial? We're here to help!

Print a patient-friendly report to share with your patient.

We can help answer any questions and connect you (or your patient) with the study team.

Schedule a time that is convenient and we’ll call you to see how we can help you and your patient.